Skip to main content

Table 4 Evidence for QTL significant at the 5% chromosome-wide level for traits related to muscle fibre distribution by chromosome obtained by half-sib analysis. Estimated significance levels (F-value), position, % of F2 variance explained by each QTL, and gene effects.

From: QTL for microstructural and biophysical muscle properties and body composition in pigs

Trait SSC Position [cM] F- Value % Variance1
ProGiF 1 0 8.7* 24.3
ProFTG/w 1 108 4.3** 6.2
Diared 1 117 3.9** 11.0
Fib/mm2 1 120 3.4* 9.5
Diaw 1 120 4.1** 11.5
ProSTO/red 1 124 4.2** 6.0
Prored 1 136 4.5** 12.6
ToF# 2 40 4.8** 15.0
ProFTO 2 100 5.8*** 18.2
CapSTO 2 123 5.6*** 17.5
Proim 3 10 3.3* 9.1
ProFTO 3 16 3.8* 11.9
DiaAnf 4 13 4.6** 12.9
Prow 4 19 3.2* 9.0
ProFTO/im 4 64 3.4* 4.8
ProFTG/w 4 80 4.5* 6.4
DiaFTO/im 4 80 4.3** 6.2
DiaGiF 4 129 4.7* 13.1
ProGiF 4 132 6.2*** 8.8
ToF# 5 75 4.3* 12.2
Prow 7 139 3.4* 9.5
ProFTO 8 55 6.0*** 18.9
ProAnF 8 97 5.1* 15.9
ProFTG 8 127 5.4** 17.0
Fib/mm2 9 50 3.9** 4.1
DiaFTG/w 9 72 3.3* 3.2
ProAnF 10 11 4.3* 13.5
ToF# 11 80 6.0** 17.3
Diaim 11 83 4.0** 11.1
Diared 11 85 3.9** 11.0
Diaw 11 86 4.7** 13.1
Fib/mm2 11 91 5.2*** 5.9
Prored 11 98 3.5* 9.9
Prow 11 98 3.4* 9.5
ProGiF 12 38 10.3*** 24.4
DiaGiF 12 56 7.4*** 17.5
Capmean 13 54 3.2* 10.0
DiaFTG/w 13 60 3.9* 5.6
Fib/mm2 13 62 4.1** 5.9
CapSTO 13 66 4.0* 12.7
ToF# 13 76 3.2* 9.3
ToF# 14 24 3.9* 12.3
ProGiF 15 32 12.7**** 15.5
DiaGiF 15 34 6.4** 15.1
Prored 16 12 3.1* 8.6
ProGiF 16 74 4.3* 13.6
Fib/mm2 17 22 3.1* 9.7
ProAnF 17 58 4.1** 5.9
  1. *: significant at the 5% chromosome-wide level, **: significant at the 1% chromosome-wide level, ***: significant at the 5% genome-wide level, ****: significant at the 1% genome-wide level
  2. 1the fraction of phenotypic variance in the F2 explained by a QTL; calculated as the proportion of residual variance of the statistical models with and without the QTL effect